National Health (Highly specialised drugs program for hospitals) Special Arrangement Amendment Instrument 2013 (No. 9) (No. PB 92 of 2013) (Cth)

PB 92 of 2013

National Health (Highly specialised drugs program for hospitals) Special Arrangement Amendment Instrument 2013 (No. 9)

National Health Act 1953

___________________________________________________________________________

I, KIM BESSELL, Assistant Secretary, Pharmaceutical Access Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Amendment Instrument under subsections 100(1) and 100(2) of the

National Health Act 1953.

Dated   20 December 2013

KIM BESSELL

Assistant Secretary

Pharmaceutical Access Branch

Pharmaceutical Benefits Division

Department of Health

___________________________________________________________________________

1       Name of Instrument

(1)This Instrument is the National Health (Highly specialised drugs program for hospitals) Special Arrangement Amendment Instrument 2013 (No.9).

(2)This Instrument may also be cited as PB 92 of 2013.

2              Commencement

This Instrument commences on 1 January 2014.

3              Amendments to PB 116 of 2010

Schedule 1 amends the National Health (Highly specialised drugs program for hospitals) Special Arrangement 2010 (PB 116 of 2010).

Schedule 1       Amendments

Section 3

[1]     Schedule 1, entry for Clozapine in the form Tablet 25 mg with the manner of administration Oral, brand Clopine 25

Omit from the column headed ‘Circumstances’: C1826, C1827, C3326, C3327            Substitute: C4371, C4411

[2]     Schedule 1, entry for Clozapine in the form Tablet 25 mg with the manner of administration Oral, brand Clozaril 25

Omit from the column headed ‘Circumstances’: C1826, C1827, C3326, C3327Substitute: C4371, C4411

[3]     Schedule 1, entry for Clozapine in the form Tablet 50 mg with the manner of administration Oral, brand Clopine 50

Omit from the column headed ‘Circumstances’: C1826, C1827, C3326, C3327Substitute: C4371, C4411

[4]     Schedule 1, entry for Clozapine in the form Tablet 100 mg with the manner of administration Oral, brand Clopine 100

Omit from the column headed ‘Circumstances’: C1826, C1827, C3326, C3327Substitute: C4371, C4411

[5]     Schedule 1, entry for Clozapine in the form Tablet 100 mg with the manner of administration Oral, brand Clozaril 100

Omit from the column headed ‘Circumstances’: C1826, C1827, C3326, C3327  Substitute: C4371, C4411

[6]     Schedule 1, entry for Clozapine in the form Tablet 200 mg with the manner of administration Oral, brand Clopine 200

Omit from the column headed ‘Circumstances’: C1826, C1827, C3326, C3327Substitute: C4371, C4411

[7]     Schedule 1, entry for Clozapine in the form Oral Liquid 50 mg per mL, 100 mL with the manner of administration Oral, brand Clopine Suspension

Omit from the column headed ‘Circumstances’: C1826, C1827, C3326, C3327Substitute: C4371, C4411

[8]     Schedule 1, entry for Ganciclovir in the form intravitreal implant 4.5 mg with manner of administration implantation, brand Vitrasert            

Omit

[9]     Schedule 1, entry for Pamidronic Acid in the form injection containing 4 vials powder for I.V. infusion containing disodium pamidronate 15 mg and 4 ampoules solvent 5 mL with manner of administration injection, brand

Aredia 15 mg

Omit

[10]   Schedule 3, entry for Clozapine

Omit

[11]   Schedule 3, entry for Clozapine, after entry for Clarithromycin, Circumstance Code C3325

Insert:

Clozapine	C4371	Where the patient is receiving treatment at/from a private hospital Schizophrenia Patient must be non-responsive to other neuroleptic agents; OR Patient must be intolerant of other neuroleptic agents. A medical practitioner should request a quantity sufficient for up to one month's supply. Up to 5 repeats will be authorised.	Compliance with Written and Telephone Authority Required procedures
C4411	Where the patient is receiving treatment at/from a public hospital Schizophrenia Patient must be non-responsive to other neuroleptic agents; OR Patient must be intolerant of other neuroleptic agents. A medical practitioner should request a quantity sufficient for up to one month's supply. Up to 5 repeats will be authorised.	Compliance with Written and Telephone Authority Required procedures - Streamlined Authority Code 4411